Why Co-Diagnostics Blasted 21% Higher on Thursday

why co diagnostics blasted 21 higher on thursday

Sumary of Why Co-Diagnostics Blasted 21% Higher on Thursday:

  • The healthcare-testing specialist’s shares closed over 21% higher on the day, due largely to news of a fresh patent awarded to the company.
  • So what Co-Diagnostics announced that its CoPrimer diagnostics platform, which underpins testing products — like its popular-for-obvious-reasons Logix Smart for COVID-19 — has been granted a patent in South Korea.
  • “We believe that this patent granted by South Korea provides additional validation of the uniqueness and versatility of the CoPrimer platform,” the company quoted CEO Dwight Egan as saying.
  • He added that the overwhelming majority of the diagnostics products the healthcare company has sold have been to repeat customers.
  • Nevertheless, it’s a relatively affluent market for the company.

Want to know more click here go to source.

From -

Generic selectors
Exact matches only
Search in title
Search in content

Site Language

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.